We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$126M
AUM Growth
+$21.3M
Cap. Flow
+$8.72M
Cap. Flow %
6.94%
Top 10 Hldgs %
36.05%
Holding
136
New
12
Increased
37
Reduced
33
Closed
1

Sector Composition

Rank Sector Weight
1 Healthcare 26.54%
2 Energy 11.74%
3 Consumer Staples 8.64%
4 Financials 6.03%
5 Technology 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMLP icon
126
Alerian MLP ETF
AMLP
$13.3B
$159K 0.13%
2,498
-459
-16% -$29.5K
VVR icon
127
Invesco Senior Income Trust
VVR
$459M
$159K 0.13%
34,376
-6,000
-15% -$27.9K
P
128
Everpure Inc
P
$32.6B
$113K 0.09%
11,500
DHF
129
BNY Mellon High Yield Strategies Fund
DHF
$172M
$105K 0.08%
30,900
CCXI
130
DELISTED
ChemoCentryx, Inc.
CCXI
$73K 0.06%
10,000
AHT
131
Ashford Hospitality Trust
AHT
$20.7M
$68K 0.05%
11
GERN icon
132
Geron
GERN
$949M
$36K 0.03%
16,000
GMO
133
DELISTED
General Moly, Inc.
GMO
$32K 0.03%
63,046
-28,000
-31% -$13.5K
AVGO icon
134
Broadcom
AVGO
$2.01T
-17,500
Closed -$309K

Similar funds

Fernwood Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Fernwood Investment Management held 136 positions worth $126M, up 20% from $104M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Fernwood Investment Management deployed $8.72M of net new capital in Q1 2017, opening 12 new positions and adding to 37 existing holdings. Its largest new stake was Ubiquiti: 20,150 shares worth $1.01M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 22% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Portola Pharmaceuticals, Inc., an estimated $397K trimmed.

  • Fernwood Investment Management's largest Q1 2017 buy was Ubiquiti: 20,150 shares worth $1.01M.
  • Fernwood Investment Management added most to Global Blood Therapeutics, Inc. in Q1 2017, an estimated $5.16M increase.
  • Fernwood Investment Management's biggest Q1 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $397K.
  • Fernwood Investment Management fully exited Broadcom in Q1 2017, selling an estimated $309K.
  • Fernwood Investment Management's ten largest holdings make up 36% of its $126M portfolio in Q1 2017.
  • Fernwood Investment Management opened 12 new positions and closed 1 in Q1 2017.
  • Fernwood Investment Management's portfolio value rose 20% quarter-over-quarter to $126M.

Based on Fernwood Investment Management's 13F filing for Q1 2017, filed 9 May 2017.